RT Journal Article
SR Electronic
T1 Additional Radiation Safety Concerns Involving Sodium Iodide-131 Capsules
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP 289
OP 290
VO 23
IS 4
A1 Michael T. Hackett
A1 Nicolaos Perdikaris
A1 Theandres T. Ruffin
YR 1995
UL http://tech.snmjournals.org/content/23/4/289.abstract
AB Objective: We studied the extent of 131I contamination within absorbent packets of activated carbon that are enclosed in one manufacturer’s packaging of 131I therapeutic capsules. Methods: Iodine-131 activity within the absorbent packets of ten 131I capsules was measured 3–5 min after opening each container and over a one workday period. Results: Initial 1311 activity of the absorbent packets ranged from 0.1% to 1.0% of the activity of the respective 131I capsules. Follow-up measurements demonstrated rapid release of 131I. Conclusion: Absorbent packets used in the packaging of 1311 capsules are a source of 131I contamination. They must be handled and stored properly to minimize potential internal exposure to the nuclear medicine staff.